BioSpace News Archive

Cyrus Biotechnology, Inc. announced today that through a collaboration with OpenEye Scientific Software, Inc., a leader in computational molecular design, capabilities have been developed that allow small molecule ligands to be processed and used with Rosetta and within the Cyrus Bench® platform for computational protein drug design.

COMPANY INCREASES FULL-YEAR 2018 GUIDANCE

The new venture will leverage the precision molecular design platforms developed by Schrödinger and accelerate them through partnership with the world-class lead optimization services provided by WuXi AppTec.

The patent covers compositions of both single and dual guide RNAs in all environments including use in human and animal cells.

Co-Developed Exam Planned to Launch In 10 US Centers in Q1 2019; Projected to be Used in 100 Vascular Surgery Training Programs Throughout US

Men who eat plenty of fermented dairy products have a smaller risk of incident coronary heart disease than men who eat less of these products, according to a new study from the University of Eastern Finland.

For the quarter, Welltower generated net income attributable to common stockholders of $0.17 per share and normalized FFO attributable to common stockholders of $1.04 per share.

Q3 2018 GAAP Loss Per Share of $0.11; Non-GAAP Performance Net Income Per Share of $4.25

Young to join Indiana-based Animal Health Company’s Leadership Team

Co-Diagnostics agrees to license CoPrimers™ for use in agricultural applications